Atjaunināt sīkdatņu piekrišanu

Ocular Pharmacotherapy [Mīkstie vāki]

  • Formāts: Paperback / softback, 450 pages, height x width: 203x114 mm, weight: 515 g, 140 Illustrations
  • Izdošanas datums: 17-Jul-2017
  • Izdevniecība: Jaypee Brothers Medical Publishers
  • ISBN-10: 935152499X
  • ISBN-13: 9789351524991
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 67,72 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 450 pages, height x width: 203x114 mm, weight: 515 g, 140 Illustrations
  • Izdošanas datums: 17-Jul-2017
  • Izdevniecība: Jaypee Brothers Medical Publishers
  • ISBN-10: 935152499X
  • ISBN-13: 9789351524991
Citas grāmatas par šo tēmu:
Ocular Pharmacotherapy concerns the use of drugs to treat diseases of the eye. This book, from the Chairman of Ophthalmology at Complutense University in Madrid, is an essential resource for residents, students and practising ophthalmologists. It provides key information regarding both the basic pharmacology of ophthalmic drugs and their use in clinical practice.





The comprehensive text consists of twenty-six chapters, incorporating an extensive review across six chapters of various anti-microbial treatments. These include commercially available antibiotics, fortified topical antibiotics, intravitreal, subconjunctival, intracorneal and oral antibiotics, antivirals, antifungals and antiparasitics.





It also includes a detailed appendix on the treatment of uveitis and covers new ophthalmic diagnostic and therapeutic formulations and delivery systems, which have been developed in recent years.





Over 140 full colour images, including numerous high-quality clinical photographs, charts and tables, enhance understanding. Ocular Pharmacotherapy provides an excellent point of reference to assist in making initial decisions on treatment, for students and professionals alike.





Key Points









Up-to-date information on new developments in ocular pharmacotherapy Extensive review of anti-microbial treatments Highly illustrated with clinical photographs, charts and tables Authored by a recognised ophthalmic specialist from Spain
Opthalmic pharmaceuticals: New formulations.
Topical Anesthetics
Ocular surface Dyes
Mydriatics and cycloplegics
Commercially available Topical Antibiotics
Fortified topical antibiotics. Intravitreal and subconjunctival antibiotics
Oral antibiotics with ophthalmic clinical usefulness
Antivirals
Antifungals
Antiparasitics.
Steroids
AINS drugs
Other antiinflamatories (tetracyclines, omega 3, cyclosporin A, tacrolimus)
Immunosupressants
Biologics
Intravitreal implants (OZURDEX, RETISERT,)
Antiglaucoma drugs
Antiangiogenics
Botulinum toxin
Vitamins, antioxidants and other dieteticals
Antiallergics
Ocular lubricants
Surgical use drugs (vancomicin, cefuroxime, fenilefrine 1.5%, lidocaine,
adrenaline, acetilcholine, tissucol, dyes (tripan blue, indocianine green,
brilliant blue, viscoelastics, silicone oil, SF6,)
Lid cleansing products
Ocular adverse reactions of systemic drugs
Ocular adverse events of topical drugs
Jose M Benitez Del Castillo MD PHD

Chairman of Ophthalmology, Complutense University, Madrid, Spain

Head of Ocular Inflammation Unit, Hospital Clinico San Carlos, Madrid, Spain





David Diaz-Valle MD





Jose Antonio Gegundez-Fernandez MD